A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Clinical trial NCT05068102 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05068102
Sponsor: Boehringer Ingelheim
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck (HNSCC)Melanoma Non-small Cell Lung Cancer (NSCLC)

Start date: 2022-03-03
Primary completion: 2026-01-22
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.